[Federal Register Volume 86, Number 7 (Tuesday, January 12, 2021)]
[Notices]
[Page 2457]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-00351]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-756]


Bulk Manufacturer of Controlled Substances Application: Cedarburg 
Pharmaceuticals

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Cedarburg Pharmaceuticals has applied to be registered as a 
bulk manufacturer of basic class(es) of controlled substance(s). Refer 
to Supplemental Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before March 15, 2021. 
Such persons may also file a written request for a hearing on the 
application on or before March 15, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on October 16, 2020, Cedarburg Pharmaceuticals 870 
Badger Circle, Grafton, Wisconsin 53024, applied to be registered as a 
bulk manufacturer of the following basic class(es) of controlled 
substance(s):

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols..................     7370  I
3, 4-Methylenedioxymethamphetamine.....     7405  I
Dimethyltryptamine.....................     7435  I
Psilocybin.............................     7437  I
Methylphenidate........................     1724  II
Nabilone...............................     7379  II
4-Anilino-N-phenethyl-4-piperidine          8333  II
 (ANPP).
Fentanyl...............................     9801  II
------------------------------------------------------------------------

    The company plans to manufacture bulk active pharmaceutical 
ingredients (API) for distribution to its customers. In reference to 
the drug code 7370 (Tetrahydrocannabinols), the company plans to bulk 
manufacture as synthetic. No other activity for this drug code is 
authorized for this registration.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-00351 Filed 1-11-21; 8:45 am]
BILLING CODE P